Cite
HARVARD Citation
Juhasz, E. et al. (n.d.). 3091 Characterization of advanced NSCLC patients with prolonged benefit after veliparib plus carboplatin/paclitaxel: Phase 2 results. European journal of cancer. pp. S629-S630. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Juhasz, E. et al. (n.d.). 3091 Characterization of advanced NSCLC patients with prolonged benefit after veliparib plus carboplatin/paclitaxel: Phase 2 results. European journal of cancer. pp. S629-S630. [Online].